Tuesday, 24 November 2020 04:04 AM
October 19, 2020 07:47 AM NPT
BRUSSELS, Oct 19: Pfizer, one of the leading companies in COVID-19 vaccine production, has manufactured hundreds of doses of drugs in Belgium, reports 9new.com.
However, Pfizer is looking forward to authorization of its COVID-19 vaccine only after the third week of November if everything goes as planned.
A number of pharmaceutical companies are seeing COVID-19 vaccines developed and distributed by the beginning of next year.
Likewise, AstraZeneca, the company behind the vaccine Australia is aligned with, says the jab could be available as soon as Christmas.
Another leading US contender, Moderna Inc, previously announced the earliest it could seek authorization of its own vaccine would be November 25.
NEW YORK, Nov 20: Pfizer Inc said it will apply to U.S. health regulators on Friday for emergency use authorization...
NEW YORK, Nov 19: Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after...